Stan V. Smith - 03 Jun 2025 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Stan V. Smith
Issuer symbol
MAIA
Transactions as of
03 Jun 2025
Net transactions value
+$106,999
Form type
4
Filing time
05 Jun 2025, 16:42:27 UTC
Previous filing
12 May 2025
Next filing
02 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smith Stan Director 444 WEST LAKE STREET, SUITE 1700, CHICAGO /s/ Stan V. Smith 05 Jun 2025 0001913199

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $50,000 +33,333 +2.6% $1.50 1,305,059 03 Jun 2025 See Footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Warrants Purchase $56,999 +33,333 $1.71 33,333 03 Jun 2025 Common Stock 33,333 $1.71 See Footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on June 3, 2025.
F2 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
F3 These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on June 3, 2025. The options are exercisable beginning on the six-month anniversary of the issuance date and expire 5-years after the initial issuance date.
F4 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust dated 1993.